XNAS · PACB
Quote not reported
Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

LABORATORY ANALYTICAL INSTRUMENTS
Not reported
Card
Relationship Map

Follow $PACB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $PACB by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
PACB
Pacific Biosciences of California, Inc.
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

76/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →or $250/yr
Cancel anytime · or Reserve · $79/moor $790/yr
Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
AI Analysis
Sovereign

Why is PACB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Pacific Biosciences of California, Inc.
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
2010
Employees
485
Country
US

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

52W high
$2.87
-39.72% from high
52W low
$1.11
35% of range
Market cap
$537.7M
Beta
1.92
Shares out
310.8M
Avg volume
15.2M
Price history computed in-house
1W
-25.75%
1M
+26.28%
3M
+27.21%
1Y
+5.49%
YTD
-7.49%
SMA 50 $1.60 · above
SMA 200 $1.60 · above
52W position 35%

PACB overview

Veridion Score
76
Registered · 2026-10-16
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PACB.Congress trackerSearch the public STOCK Act disclosure ledger.Thematic map · TechBio & AI Drug DiscoveryMethodologyReview score inputs, coverage rules, and limitations.
Public disclosures

Congress activity in PACB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

PACB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PACB in this window.
Lobbying spend

PACB lobbying filings, year to date.

Registered lobbying filings matched to Pacific Biosciences of California, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PACB in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for PACB.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.